Jefferies Group’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Jefferies Group’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,000	Closed	-$27K	–	2733
2016 Q3	$27K	Buy	+3,000	New	+$21.3K	﹤0.01%	2125
2016 Q2	–	Sell	-385,495	Closed	-$1.77M	–	2726
2016 Q1	$1.77M	Buy	+385,495	New	+$1.55M	0.01%	901
2015 Q3	–	Sell	-111,605	Closed	-$1.76M	–	3792
2015 Q2	$1.76M	Buy	+111,605	New	+$1.36M	0.01%	976

Jefferies Group's RPTP Position: Q4 2016 in Review

Jefferies Group sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 3,000 shares — an estimated $27K sold.

Jefferies Group first reported a position in RPTP in Q2 2015 and held it in 3 quarters. The position peaked at $1.77M in Q1 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Jefferies Group reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Jefferies Group sold 3,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $27K.
Jefferies Group first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2015 and held it in 3 quarters.
Jefferies Group's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.77M in Q1 2016.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Jefferies Group's 13F filing for Q4 2016, filed 14 Feb 2017.